Our goal is to determine the efficacy and parameters of application of employing monoclonal antibodies against Ieukocyte adhesion molecules to reduce ischemic cell damage after middle cerebral artery (MCA) occlusion in the rat. Our underlying hypothesis is that leukocytes, primarily neutrophils, contribute to ischemic cell damage after transient MCA occlusion. Therefore, by blocking adhesion molecule binding sites on the Ieukocyte, adhesion of the leukocyte, to the endothelium and subsequent emigration of the leukocyte into the brain parenchyma will be reduced, and concomitantly ischemic cell damage will be reduced. We will test-the effect of administration of three antibodies, anti-CDt t b, anti-CDt 8, and anti-VLA-4 on -ischemic - cell damage. Anti-CDt lb and anti-CDt 8 monoclonal antibodies will block neutrophil and monocyte adherence and emigration, while the anti-VLA-4 antibody will reduce monocytes within the ischemic lesion. A dose-response for antibody administration will be obtained as function of duration of the lVICA. Since the inflammatory response occurs well into the reperfusion period, we will also test the efficacy of administering these antibodies after onset of reperfusion, and identify the longest duration of reperfusion for which- this -intervention is effective in reducing ischemic cell damage. The mechanisms by which these leukocyte anti-adhesion molecule monoclonal antibodies reduce ischemic cell damage will be investigated. For treatment with anti-adhesion molecule antibodies and with isotype matched, controls, leukocytes (neutrophils and monocytesj will be correlated to ischemic cell damage within regions of the ischemic tissue, and neutrophil numbers will be counted using a myeloperoxidase assay. Quantitative autoradiography will be employed to measure cerebral blood flow and the permeability of the blood-brain-barrier (RlSA, AlB), with and without treatment. The proposed studies will optimize treatment of MCA occlusion and define the limits of applicability (duration of ischemia and reperfusion) of this promising therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS034184-04
Application #
2703065
Study Section
Neurology A Study Section (NEUA)
Program Officer
Jacobs, Tom P
Project Start
1995-07-15
Project End
1999-04-30
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Henry Ford Health System
Department
Neurology
Type
Schools of Medicine
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Zhang, R L; Zhang, Z G; Chopp, M (1999) Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat. Neurology 52:273-9
Zhang, Z; Davies, K; Prostak, J et al. (1999) Quantitation of microvascular plasma perfusion and neuronal microtubule-associated protein in ischemic mouse brain by laser-scanning confocal microscopy. J Cereb Blood Flow Metab 19:68-78
Chopp, M; Li, Y; Jiang, N (1999) Increase in apoptosis and concomitant reduction of ischemic lesion volume and evidence for synaptogenesis after transient focal cerebral ischemia in rat treated with staurosporine. Brain Res 828:197-201
Chopp, M; Zhang, R L; Zhang, Z G et al. (1999) The clot thickens--thrombolysis and combination therapies. Acta Neurochir Suppl 73:67-71
Zhang, R L; Zhang, Z G; Chopp, M et al. (1999) Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. Stroke 30:624-9
Zhang, R; Chopp, M; Zhang, Z et al. (1998) The expression of P- and E-selectins in three models of middle cerebral artery occlusion. Brain Res 785:207-14
Jiang, Q; Zhang, Z G; Zhang, R L et al. (1998) Diffusion, perfusion, and T2 magnetic resonance imaging of anti-intercellular adhesion molecule 1 antibody treatment of transient middle cerebral artery occlusion in rat. Brain Res 788:191-201
Jiang, Q; Zhang, R L; Zhang, Z G et al. (1998) Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab 18:758-67
Li, Y; Powers, C; Jiang, N et al. (1998) Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat. J Neurol Sci 156:119-32
Li, Y; Jiang, N; Powers, C et al. (1998) Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 29:1972-80;discussion 1980-1

Showing the most recent 10 out of 27 publications